Wells Fargo’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-493
Closed -$2.61K 7432
2025
Q2
$2.61K Sell
493
-1,438
-74% -$7.74K ﹤0.01% 6180
2025
Q1
$8.54K Buy
1,931
+1,046
+118% +$6.76K ﹤0.01% 5923
2024
Q4
$6.19K Buy
885
+302
+52% +$3.32K ﹤0.01% 6027
2024
Q3
$8.46K Sell
583
-23
-4% -$1.04K ﹤0.01% 5834
2024
Q2
$44.2K Sell
606
-168
-22% -$12.9K ﹤0.01% 5349
2024
Q1
$45.8K Sell
774
-216
-22% -$11.9K ﹤0.01% 5292
2023
Q4
$72.5K Buy
990
+423
+75% +$17.4K ﹤0.01% 5100
2023
Q3
$22K Sell
567
-453
-44% -$23K ﹤0.01% 5558
2023
Q2
$58.8K Buy
1,020
+857
+526% +$52K ﹤0.01% 5352
2023
Q1
$10.6K Hold
163
﹤0.01% 5844
2022
Q4
$4.47K Buy
163
+1
+0.6% +$27 ﹤0.01% 5808
2022
Q3
$4K Buy
162
+104
+179% +$3.56K ﹤0.01% 5992
2022
Q2
$1K Sell
58
-541
-90% -$27.2K ﹤0.01% 6629
2022
Q1
$48K Sell
599
-440
-42% -$36.3K ﹤0.01% 5681
2021
Q4
$96K Sell
1,039
-1,034
-50% -$117K ﹤0.01% 5665
2021
Q3
$259K Buy
2,073
+2,020
+3,811% +$227K ﹤0.01% 4993
2021
Q2
$6K Sell
53
-377
-88% -$45.7K ﹤0.01% 6300
2021
Q1
$65K Sell
430
-893
-67% -$124K ﹤0.01% 5688
2020
Q4
$152K Buy
1,323
+235
+22% +$21.6K ﹤0.01% 5197
2020
Q3
$85K Sell
1,088
-213
-16% -$17.4K ﹤0.01% 5324
2020
Q2
$143K Buy
1,301
+55
+4% +$6.36K ﹤0.01% 5064
2020
Q1
$136K Sell
1,246
-835
-40% -$110K ﹤0.01% 4906
2019
Q4
$330K Sell
2,081
-281
-12% -$41.5K ﹤0.01% 4677
2019
Q3
$348K Buy
2,362
+109
+5% +$12.1K ﹤0.01% 4614
2019
Q2
$262K Buy
2,253
+1,956
+659% +$183K ﹤0.01% 4817
2019
Q1
$32K Hold
297
﹤0.01% 5422
2018
Q4
$24K Buy
297
+215
+262% +$26.1K ﹤0.01% 5730
2018
Q3
$13K Buy
+82
New +$14K ﹤0.01% 5938

Other funds holding VRCA